BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20369484)

  • 21. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of urokinase on renal interstitial inflammation in rats with chronic cyclosporine A nephropathy and its possible mechanism].
    Wang Y; Ma L; Tong JR; Luo ZM; He F
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):835-8. PubMed ID: 18504214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of urokinase-type plasminogen activator production by rat mammary myoepithelial cells.
    Warburton MJ; Dundas SR; Gusterson BA; O'Hare MJ
    Exp Cell Res; 1996 Oct; 228(1):76-83. PubMed ID: 8892973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta 1 in Balkan endemic nephropathy.
    Dukanović L; Lezaić V; Miljković D; Momcilović M; Bukvić D; Marić I; Miljković Z; Marinković J; Mostarica-Stojković M
    Nephron Clin Pract; 2009; 111(2):c127-32. PubMed ID: 19147994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction].
    Song SJ; Hu JB; Wang HX; Wen SQ; Ding MP; Huang JZ
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1583-5. PubMed ID: 14642114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The urokinase system in patients with intermittent and persistent allergic rhinitis.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):685-8. PubMed ID: 18832910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T; Kobayashi H; Wakahara K; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    FEBS Lett; 2004 Oct; 576(3):408-16. PubMed ID: 15498571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
    Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of TGF-beta(1-3) in serosal fluid during abdominal surgery and their effect on in vitro human mesothelial cell proliferation.
    Falk P; Bergström M; Palmgren I; Holmdahl L; Breimer ME; Ivarsson ML
    J Surg Res; 2009 Jun; 154(2):312-6. PubMed ID: 19062040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus.
    Yener S; Demir T; Akinci B; Bayraktar F; Kebapcilar L; Ozcan MA; Biberoglu S; Yesil S
    Diabetes Res Clin Pract; 2007 May; 76(2):193-8. PubMed ID: 17014924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preeclampsia in the 21st century: Unresolved questions concerning etiology.
    Pluta R; Ułamek-Kozioł M; Furmaga-Jabłońska W; Czuczwar SJ
    Nutrition; 2015 Sep; 31(9):1179-81. PubMed ID: 26233878
    [No Abstract]   [Full Text] [Related]  

  • 35. Methylation-dependent circulating microRNA 510 in preeclampsia patients.
    Sekar D; Lakshmanan G; Mani P; Biruntha M
    Hypertens Res; 2019 Oct; 42(10):1647-1648. PubMed ID: 31114031
    [No Abstract]   [Full Text] [Related]  

  • 36. Circulating Transforming Growth Factor-β1 Levels in Preeclamptic Women: a Meta-analysis.
    Wang X; Wang T; Wang J; Niu X; Wang K; Hao Z; Gao H
    Reprod Sci; 2023 Jun; 30(6):1952-1964. PubMed ID: 36574144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epiregulin promotes trophoblast epithelial-mesenchymal transition through poFUT1 and O-fucosylation by poFUT1 on uPA.
    Cui X; Wang H; Li Y; Chen T; Liu S; Yan Q
    Cell Prolif; 2020 Feb; 53(2):e12745. PubMed ID: 31889361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor β signaling in uterine development and function.
    Li Q
    J Anim Sci Biotechnol; 2014; 5(1):52. PubMed ID: 25478164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of plasma uPA and TGF-beta1 in patients with preeclampsia].
    Wang XJ; Zhou ZY; Xu YJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):118-20. PubMed ID: 20369484
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.